GH Research PLC (GHRS)

Currency in USD
15.75
0.00(0.00%)
Real-time Data·
GHRS is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
15.4816.15
52 wk Range
7.9820.50
Key Statistics
Prev. Close
15.75
Open
15.75
Day's Range
15.48-16.15
52 wk Range
7.98-20.5
Volume
125.69K
Average Volume (3m)
444.4K
1-Year Change
75.5284%
Book Value / Share
4.7
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
GHRS Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
32.61
Upside
+107.04%
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

GH Research PLC News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

GH Research PLC Company Profile

GH Research PLC, together with its subsidiary, a clinical-stage biopharmaceutical company, engages in developing treatments for depression in the United States. Its lead product candidate is GH001, an inhalable mebufotenin product candidate, which is in phase 2b clinical trial for treating patients with treatment-resistant depression; and in phase 2a clinical trial for treating bipolar II disorder and a current major depressive episode, as well as female patients with postpartum depression. The company also develops GH002, an intravenous mebufotenin product candidate, which is in phase 1 clinical pharmacology trial in healthy volunteers focusing on psychiatric and neurological disorders. The company was founded in 2018 and is based in Dublin, Ireland.

Compare GHRS to Peers and Sector

Metrics to compare
GHRS
Peers
Sector
Relationship
P/E Ratio
−22.8x−5.3x−0.6x
PEG Ratio
−2.87−0.110.00
Price/Book
3.4x3.6x2.6x
Price / LTM Sales
-5.5x3.4x
Upside (Analyst Target)
106.3%199.2%42.0%
Fair Value Upside
Unlock19.0%5.8%Unlock

Analyst Ratings

9 Buy
0 Hold
0 Sell
Ratings:
9 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 32.61
(+107.04% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Needham
Buy29.00+84.13%19.00MaintainJan 06, 2026
Canaccord Genuity
Buy39.00+147.62%35.00MaintainJan 06, 2026
Citizens
Buy39.00+147.62%-MaintainJan 06, 2026
TD Cowen
Buy---MaintainJan 05, 2026
Guggenheim
Buy29.00+84.13%-MaintainJan 05, 2026

Earnings

Latest Release
Nov 06, 2025
EPS / Forecast
-0.23 / -0.24
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

GHRS Income Statement

People Also Watch

3.3199
SIDU
-9.79%
13.750
WVE
-0.51%
23.980
CAPR
-0.91%
13.870
VTYX
-0.07%
25.74
ALMS
-1.25%

FAQ

What Is the GH Research (GHRS) Premarket Price Today?

The GH Research (GHRS) premarket price is 15.71. Premarket price change units: -0.04. Premarket percentage change: -0.25%. Premarket volume: 490.00. Current date: 21 Jan 2026. Previous close: 15.75

What Stock Exchange Does GH Research Trade On?

GH Research is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for GH Research?

The stock symbol for GH Research is "GHRS."

What Is the GH Research Market Cap?

As of today, GH Research market cap is 981.93M.

What Is GH Research's Earnings Per Share (TTM)?

The GH Research EPS (TTM) is -0.73.

When Is the Next GH Research Earnings Date?

GH Research will release its next earnings report on 25 Feb 2026.

From a Technical Analysis Perspective, Is GHRS a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.

How Many Times Has GH Research Stock Split?

GH Research has split 0 times.

How Many Employees Does GH Research Have?

GH Research has 50 employees.

What is the current trading status of GH Research (GHRS)?

As of 21 Jan 2026, GH Research (GHRS) is trading at a price of 15.75, with a previous close of 15.75. The stock has fluctuated within a day range of 15.48 to 16.15, while its 52-week range spans from 7.98 to 20.50.

What Is GH Research (GHRS) Price Target According to Analysts?

The average 12-month price target for GH Research is USD32.61, with a high estimate of USD39 and a low estimate of USD25. 9 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +107.04% Upside potential.

What Is the GHRS Premarket Price?

GHRS's last pre-market stock price is 15.71. The pre-market share volume is 490.00, and the stock has decreased by -0.04, or -0.25%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.